Exelixis
EXEL
#1347
Rank
NZ$28.82 B
Marketcap
NZ$118.14
Share price
-1.82%
Change (1 day)
56.06%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: NZ$132.99 NZD on 2026-11-04

Lowest end of day price: NZ$2.36 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 47.46%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
NZ$494.42 1.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.09-0.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$796.35-0.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$85.04 1.00%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$244.44 0.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$107.49 0.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$87.31-0.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$0.78-9.03%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$27.42 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA